[201T1 computed tomography using dipyridamole for assessing dilated cardiomyopathy]

Area of Science:

• Cardiology
• Nuclear Medicine
• Medical Imaging

Background:

• Dilated cardiomyopathy (DCM) is a significant cardiac condition affecting left ventricular function.
• Accurate assessment of coronary circulation is crucial for managing DCM patients.
• Non-invasive imaging techniques are vital for evaluating myocardial perfusion.

Purpose of the Study:

• To assess the utility of dipyridamole-stress thallium-201 emission computed tomography (ECT) for evaluating coronary circulation in patients with DCM.
• To correlate findings from thallium-201 ECT with left ventricular function and wall motion abnormalities.

Main Methods:

• 18 patients with DCM underwent dipyridamole-stress thallium-201 ECT.
• Maximal inducible coronary vasodilation was achieved using dipyridamole (0.56 mg/kg).
• Thallium-201 was administered, and ECT data were acquired at 10 minutes and 3 hours post-injection for visual interpretation.

Main Results:

• Perfusion defects were observed in all patients on dipyridamole-stress images.
• Eight patients (45%) demonstrated redistribution on delayed ECT images.
• Patients with redistribution showed significantly better left ventricular function (24.7% fractional shortening) compared to those without (18.0% fractional shortening).
• Segments with redistribution exhibited less severe wall motion abnormalities.

Conclusions:

• Redistribution thallium-201 ECT imaging using dipyridamole is a valuable tool for assessing coronary circulation in DCM.
• The presence of redistribution correlates with improved left ventricular function and less severe wall motion abnormalities in DCM patients.